M. Debette‐Gratien

发表

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.

V. de Lédinghen, D. Samuel, J. Dumortier, 2019, Journal of hepatology.

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, JHEP reports : innovation in hepatology.

Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study

V. de Lédinghen, D. Samuel, J. Dumortier, 2018, Alimentary pharmacology & therapeutics.

HybridKnife high-pressure glycerol jet injection for endoscopic submucosal dissection increases procedural ease and speed: a randomised study in pigs and a human case series

D. Sautereau, S. Kerever, T. Tabouret, 2016, Surgical Endoscopy.

Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study.

T. de Baère, C. Lepage, G. Deplanque, 2020, Clinics and research in hepatology and gastroenterology.

Pravastatin combination with Sorafenib does not improve survival in advanced Hepatocellular Carcinoma.

O. Bouché, J. Seitz, J. Jouve, 2019, Journal of hepatology.

A Placebo‐Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

V. de Lédinghen, P. Potier, F. Zoulim, 2018, The New England journal of medicine.

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, Journal of Cannabis Research.

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?

V. de Lédinghen, D. Samuel, J. Dumortier, 2015, PloS one.

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

V. de Lédinghen, T. Asselah, D. Thabut, 2021, BMC Infectious Diseases.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Journal of hepatology.

High-pressure injection of glycerol with HybridKnife for ESD is feasible and increases the ease and speed of the procedure: an in vivo study in pigs and first use in human

D. Sautereau, T. Tabouret, C. Couquet, 2015, Surgical Endoscopy.

12 Weeks of a Ribavirin‐Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation

J. Dumortier, C. Cagnot, A. Tran, 2018, Hepatology.

Direct‐acting antiviral agent–based regimen for HCV recurrence after combined liver‐kidney transplantation: Results from the ANRS CO23 CUPILT study

V. de Lédinghen, D. Samuel, J. Dumortier, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Recipient Selection for Optimal Utilization of Discarded Grafts in Liver Transplantation

X. Causse, P. Bucur, A. Tellier, 2018, Transplantation.

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

P. Potier, F. Zoulim, A. Rousseau, 2017 .

Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.

D. Samuel, G. Launoy, K. Boudjema, 2021, Clinics and research in hepatology and gastroenterology.

Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients

D. Samuel, G. Launoy, J. Dumortier, 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Treatment and prognosis of acute severe autoimmune hepatitis

M. Rudler, P. Potier, D. Samuel, 2017 .

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study.

Leroy, D. Samuel, J. Dumortier, 2016 .

1422 END OF TREATMENT RESPONSE AFTER PROTEASE INHIBITOR (PI)- BASED THERAPY FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC EUROPEAN EXPERIENCE

D. Samuel, J. Dumortier, F. Durand, 2013 .

Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)

V. de Lédinghen, J. Zucman‐Rossi, D. Thabut, 2023, Quality of Life Research.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Journal of hepatology.